BVS:NASDAQ, Bioventus Inc.

BVS stock overview

Bioventus Inc. (BVS:NASDAQ) closed at $13.71 on October 15, 2026, up 1.56% on the day. The stock trades 13.7% below its 52-week high of $15.89 and 111.9% above its 52-week low of $6.47. Over the past year, it gained 94.8%. Bioventus Inc. is part of the Health Care sector.

Key figures

Price
$13.71
Day change
+1.56%
Volume
111,387
Average volume
601,840
Market cap
936M+
52-week range
$6.47 – $15.89
50-day average
$13.70
200-day average
$10.51

Performance

5D 1M 3M 6M 1Y
-0.22% +3.85% +11.94% +31.32% +94.81%

Price action over the past year

In 252 trading sessions since October 14, 2025, BVS closed higher on 132 days (52%). Its best day was November 4, 2025 (+15.09%) and its worst was May 21, 2026 (-13.21%). The stock moved 10% or more in a single session 5 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

BVS news

About Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing orthobiologic products for the treatment of patients suffering from a broad array of musculoskeletal conditions. The products of the company include Ultrasound Bone Healing, Joint Therapies, and Bioventus Surgical.

Find more stocks like BVS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.